Nephrocare Health Services, which operates the NephroPlus dialysis network, has strengthened its presence in India and international markets by adding 51 clinics during the first half of FY2026-27. The expansion includes 40 clinics in India and 11 in the Philippines.
The Philippines expansion comprised NephroPlus Expands Dialysis Network with 51 New Clinics Across India and the Philippines
10 acquired facilities and one newly established centre, further consolidating the company’s position in the country’s dialysis services market.
The company’s overall network has grown to 570 clinics across six countries, including India, the Philippines, Uzbekistan, Nepal, Saudi Arabia and Kazakhstan. Its recent entry into Kazakhstan through the acquisition of two dialysis clinics in Almaty marks another step in its international expansion strategy.
Financially, NephroPlus reported consolidated revenue of ₹585.2 crore for the first half of FY27, registering a 23.6% year-on-year increase. Adjusted EBITDA rose 15.3% to ₹134.4 crore, while the company delivered more than 21 lakh dialysis treatments during the period, reflecting 12.6% growth.
India continues to be the company’s largest market, while the Philippines remains a major contributor to its overseas operations. NephroPlus plans to sustain its expansion momentum, targeting approximately 40–50 additional clinics annually in India and 10–15 in the Philippines.
The company is also strengthening its operational capabilities through initiatives such as the NephroPlus International Dialysis Academy (NIDA), aimed at developing a skilled workforce of renal care professionals to support its growing international network.
With continued investments in infrastructure, acquisitions and new market opportunities, NephroPlus is positioning itself to expand access to organised dialysis services across domestic and international markets.
